Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Articles, Neurobiology of Disease

Early and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model

Danielle Arbour, Elsa Tremblay, Éric Martineau, Jean-Pierre Julien and Richard Robitaille
Journal of Neuroscience 14 January 2015, 35 (2) 688-706; https://doi.org/10.1523/JNEUROSCI.1379-14.2015
Danielle Arbour
1Département de neurosciences, Université de Montréal, Montréal, Québec H3C 3J7, Canada,
2Groupe de recherche sur le système nerveux central, Université de Montréal, Station centre-ville, Montréal, Québec H3C 3J7, Canada, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elsa Tremblay
1Département de neurosciences, Université de Montréal, Montréal, Québec H3C 3J7, Canada,
2Groupe de recherche sur le système nerveux central, Université de Montréal, Station centre-ville, Montréal, Québec H3C 3J7, Canada, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Éric Martineau
1Département de neurosciences, Université de Montréal, Montréal, Québec H3C 3J7, Canada,
2Groupe de recherche sur le système nerveux central, Université de Montréal, Station centre-ville, Montréal, Québec H3C 3J7, Canada, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Pierre Julien
3Département de psychiatrie et de neurosciences, Université Laval, Québec G1V 0A6, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Robitaille
1Département de neurosciences, Université de Montréal, Montréal, Québec H3C 3J7, Canada,
2Groupe de recherche sur le système nerveux central, Université de Montréal, Station centre-ville, Montréal, Québec H3C 3J7, Canada, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Morphology is unaltered at presymptomatic stage of the disease. A, Confocal images of NMJs from controls (WT and SOD1WT) and an ALS mouse model (SOD1G37R). P120 soleus NMJs were labeled for the nerve terminals (NT) (synaptic vesicular protein 2 and NF-M, green), PSC (S100β, cyan), and postsynaptic nAChRs (α-bungarotoxin, red). Note the similar staining patterns between each animal group. B, Confocal images of soleus muscle from an SOD1G37R mouse. Muscle fibers were stained using anti-myosin heavy chain (MHC) monoclonal antobodies: Type I fibers (MHC-I; blue), Type IIa fibers (MHC-IIa; green), and α-bungarotoxin (red) to identify the localization of the endplates. Note the alternation of slow- and fast-twitch fibers in the soleus muscle. C, Histogram of the percentage of surface fibers in the soleus of each animal group. D, Histogram of the percentage of surface NMJs per fiber type in the soleus of each animal groups. Histograms in C and D represent mean ± SEM. Scale bars: A, 10 μm; B, 50 μm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Altered PSC excitability at presymptomatic stage of the disease. A, False color images of PSCs (*) loaded with fluorescent Ca2+ indicator Fluo-4 AM, before (baseline), during (stimulation), and after (recovery) motor nerve stimulation at NMJs of WT, SOD1WT, and SOD1G37R. Representative changes in fluorescence are illustrated on the right for the PSCs indicated by the arrowhead. B, Histogram depicting the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSCs by transmitter release evoked by motor nerve stimulation (50 Hz, 5 s). PSCs at NMJs from SOD1G37R mice had larger Ca2+ responses (one-way ANOVA, p = 0.0004) C, Examples of an NMJ imaged during Ca2+ imaging experiment (top) and the same NMJ imaged after MHC and BTX staining (bottom). This NMJ was associated with a fiber Type I (MHC-I, blue) and not a fiber Type IIa (MHC-IIa, green). D, Histogram illustrating the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSCs by motor nerve stimulation as a function of each fiber type. The altered PSC excitability did not correlate with motor neuron vulnerability at a presymptomatic stage of the disease. Scale bars: A, 10 μm; C, 20 μm. *p < 0.05, **p < 0.01.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Enhanced synaptic transmission at NMJs from SOD1G37R mice at presymptomatic stage of the disease. A, Examples of spontaneous MEPP recordings from WT, SOD1WT, and SOD1G37R NMJs. Histogram showing the mean ± SEM of the amplitude (B) and the frequency (C) of the MEPP. D, Examples of EPPs evoked by paired-pulse stimulation of the motor nerve (10 ms interval) from WT, SOD1WT, and SOD1G37R NMJs. E, Histogram showing the mean ± SEM of the amplitude of the first EPP. F, Calculated quantal content obtained from electrophysiological recordings of synaptic transmission and determined as EPP amplitude/mEPP amplitude. NMJs from SOD1G37R mice had higher quantal content. G, Calculated PPF obtained from electrophysiological recordings of synaptic transmission and determined as the mean amplitude of the second EPPs divided by the mean amplitude of the first EPPs. *p < 0.05, **p < 0.01, ***p < 0.001.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    PSC decoding ability is unaffected by an increase in transmitter release. A, Changes of EPP amplitude before and during (red bar) bath application of TEA (0.2 mm). Insets, Examples of EPPs (black) before and 30 min after TEA application (red). TEA increased synaptic transmission of both WT and SOD1G37R nerve terminals. Effect of TEA (0.2 mm) bath application on corresponding PSC Ca2+ responses induced by synaptic activity (50 Hz, 5 s) from WT (B) and SOD1G37R (C) animals. Gray zones represent the mean ± SEM of the amplitude of the Ca2+ responses elicited by motor nerve stimulation in control (without TEA). PSC Ca2+ responses elicited by potentiated WT nerve terminals remain smaller than those triggered by the SOD1G37R and were not significantly different from the ones without TEA (unpaired t test, p > 0.05). Ca2+ responses elicited in PSCs by local applications of ATP in WT (D) and SOD1G37R NMJs (E). The ability of PSCs to produce larger Ca2+ responses was not affected by TEA because local application of ATP (red arrow) elicited larger Ca2+ responses in PSC from WT and SOD1G37R mice. In B–D, black and grey traces represent the mean and SEM, respectively.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    PSC Ca2+ responses to local application of ATP and muscarine. A, False color confocal images of PSCs (*) loaded with fluorescent Ca2+ indicator Fluo-4 AM, before (baseline), during (ATP application), and after (recovery) local ATP applications at NMJs of WT, SOD1WT, and SOD1G37R. Representative changes in fluorescence are illustrated on the right for the PSCs indicated by the arrowhead. Higher magnification of PSCs marked with the arrowhead in left are illustrated on the three other images for each group. B, Histogram depicting the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSC by ATP application. C, Histograms depicting the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSC by ATP application as a function of fiber type. D–F, Similar representation as in A–C, but illustrating the muscarine application. There was no statistical difference between the different animal groups either for the ATP or the muscarine application (one-way ANOVA, p > 0.05). Scale bar, 10 μm.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Larger contribution of mAChR activation of PSCs during synaptic transmission in SOD1G37R mice. PSC Ca2+ responses evoked by motor nerve stimulation in the presence of atropine (5–20 μm) for WT (A) and SOD1G37R (B) mice. No Ca2+ responses were elicited in PSCs by local application of muscarine in the presence of atropine while responses were still elicited by local application of ATP. Dark trace represents the average of PSC Ca2+ responses. Dotted line indicates the SEM. Gray boxes represent the mean ± SEM of the amplitude of the Ca2+ responses elicited by nerve stimulation or agonist application without atropine. Histogram depicting the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSCs by transmitter release evoked by motor nerve stimulation (50 Hz, 5 s) during bath application of mAChR antagonist (atropine, 5–20 μm) for WT (C) and SOD1G37R (D) mice. Histogram depicting the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSC by motor nerve stimulation in presence of atropine as a function of each fiber type for WT (E) and SOD1G37R (F) mice. *p < 0.05, **p < 0.01, ***p < 0.001.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Enhanced synaptic transmission at NMJs from SOD1G37R mice at preonset stage of the disease. A, Traces of spontaneous activity (MEPPs) recorded from WT and SOD1G37R NMJs. Histogram showing the mean ± SEM of the amplitude (B) and the frequency (C) of MEPP events. D, Examples of EPPs evoked by paired-pulse stimulation (10 ms interval) from WT and SOD1G37R NMJs. E, Histogram showing the mean ± SEM of the amplitude of the first EPP. F, Histogram showing the quantal content determined as the ratio of EPP amplitude/mEPP amplitude. NMJs from SOD1G37R mice had a larger quantal content. G, Histogram showing the PPF determined as the mean amplitude of the second EPPs divided by the mean amplitude of the first EPPs. *p < 0.05.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Altered PSC excitability at preonset stage of the disease. A, Dark traces represent the mean ± SEM of the Ca2+ responses elicited in PSCs by transmitter release evoked by motor nerve stimulation (50 Hz, 5 s) at NMJs of WT and SOD1G37R. Larger Ca2+ responses were elicited in PSCs of NMJs from SOD1G37R mice (unpaired t test, p = 0.0006). Blue traces represent the mean ± SEM of the PSC nerve-evoked (50 Hz, 5 s) Ca2+ responses in presence of atropine (20 μm) for WT and SOD1G37R mice. PSC Ca2+ responses of WT (unpaired t test, p = 0.0129) and SOD1 mice (unpaired t test, p = 0.0016) were significantly smaller in the presence of atropine; this represents a 42% and 85% contribution of muscarinic signaling during synaptic transmission, respectively. B, Histograms depicting the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSCs by motor nerve stimulation in the presence of atropine depending of each type of fiber for WT and SOD1G37R (C) mice. The altered PSC-detecting ability did not correlate with MN vulnerability at a preonset stage of the disease. *p < 0.05, **p < 0.01.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    PSC Ca2+ responses to local application of ATP and muscarine at preonset stage of the disease. A, False color confocal images of PSCs (*) loaded with fluorescent Ca2+ indicator Fluo-4 AM, before (baseline), during (ATP application), and after (recovery) local ATP applications at NMJs of WT and SOD1G37R. Representative changes in fluorescence are illustrated on the right for the PSCs indicated by the arrowhead. Higher magnification of PSCs marked with the arrowhead in left are illustrated on the three other images for each group. B, Histogram depicting the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSCs by ATP application. C, Histograms depicting the mean ± SEM of the amplitude of the Ca2+ responses elicited in PSC by ATP as a function of each fiber type. D–F, Similar representation as in A–C, but for muscarine application. Note the statistical difference between the different animal groups for the muscarine application and for the PSC Ca2+ responses associated with fiber Type IIa for ATP and muscarine application. Scale bar, 10 μm. ***p < 0.001.

  • Figure 10.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 10.

    Timeline of changes in NMJ structure and function at presymptomatic stages of the disease in SOL muscle. Summary of the changes in the presynaptic properties (top), PSC properties (middle), and the morphological features (bottom) is presented as a function of the age of the animals. It shows that synaptic properties are observed early and only in Type I fibers and maintained throughout. However, PSC properties are altered in both fiber types and further evolve at a presymptomatic stage. Morphological features are normal at P120 but altered at the presymptomatic stage. ↑ indicates a significant increase in SOD1 compared with WT, and “No ≠” indicates that there was no statistical difference.

Tables

  • Figures
    • View popup
    Table 1.

    Definition and criteria used in the morphological analysis of NMJs

    CriteriaDefinition
    Presynaptic(1) DenervationPartial: when part of the endplate is not recovered by the presynaptic nerve terminal.
    Complete: when the presynaptic element is absent from the endplate.
    (2) Terminal sproutingWhen the presynaptic element, originating from the endplate, extends at least 20 μm away in any direction or contacts another NMJ. Only sprouts on NMJs fully innervated by a myelinated axon were counted as originating from that NMJ.
    (3) PolyinnervationWhen at least two distinct axons or sprouts were seen entering a single postsynaptic site. Sprouts from unknown origin on partially denervated NMJs or NMJs without a visible large myelinated axon were automatically counted as a source of innervation rather than a sprout originating from that endplate.
    Postsynaptic(4) Ectopic AChRWhen two nAChR clusters of at least 3 μm of diameter belonging to the same endplate were at least separated by 5 μm. nAChRs are considered as belonging to the same endplate if they are on the same muscle fiber as evaluated by background fluorescence or transmitted light images.
    (5) Faint clustered nAChRWhen the postsynaptic site was noticeably faint, clustered, and had a lack of organization reminiscent of an immature NMJ (Darabid et al., 2013).
    Glia(6) Incomplete glial coverageWhen glial cells were not fully covering the presynaptic element. Only en face NMJs were analyzed because of the limited penetration of the S100β antibody in the tissue.
    (7) Glial sproutingSprouting: when PSCs extended a process associated with a presynaptic sprout.
    Bridge: when at least one PSC extended a process at least 20 μm away or contacting another NMJ without being associated with a presynaptic element.
    • View popup
    Table 2.

    Percentage of NMJs that meet criteria used in the morphological analysis for each animal group

    CriteriaWTSOD1WTSOD1G37Rp
    Presynaptic(1) Denervation01.3 ± 1.300.4053
    (2) Terminal sprouting1.0 ± 1.02.3 ± 2.300.5589
    (3) Polyinnervation03.0 ± 1.800.1007
    Postsynaptic(4) Ectopic AChR011.4 ± 3.72.5 ± 1.40.3939
    (5) Faint clustered nAChR9.2 ± 3.411.4 ± 3.76.4 ± 2.60.5648
    Glia(6) Incomplete glial coverage000NA
    (7) Glial sprouting2.8 ± 1.72.8 ± 2.83.2 ± 1.90.9871
    • NA, Not applicable.

Back to top

In this issue

The Journal of Neuroscience: 35 (2)
Journal of Neuroscience
Vol. 35, Issue 2
14 Jan 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Early and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Early and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model
Danielle Arbour, Elsa Tremblay, Éric Martineau, Jean-Pierre Julien, Richard Robitaille
Journal of Neuroscience 14 January 2015, 35 (2) 688-706; DOI: 10.1523/JNEUROSCI.1379-14.2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Early and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model
Danielle Arbour, Elsa Tremblay, Éric Martineau, Jean-Pierre Julien, Richard Robitaille
Journal of Neuroscience 14 January 2015, 35 (2) 688-706; DOI: 10.1523/JNEUROSCI.1379-14.2015
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • motor unit properties
  • muscarinic receptors
  • perisynaptic Schwann cells
  • SOD1
  • synaptic transmission

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Memory Retrieval Has a Dynamic Influence on the Maintenance Mechanisms That Are Sensitive to ζ-Inhibitory Peptide (ZIP)
  • Neurophysiological Evidence for a Cortical Contribution to the Wakefulness-Related Drive to Breathe Explaining Hypocapnia-Resistant Ventilation in Humans
  • Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
Show more Articles

Neurobiology of Disease

  • Unveiling cortical criticality changes along the prodromal to the overt continuum of alpha-synucleinopathy
  • Atypical Retinal Ganglion Cell Function in a Mouse Model of Fragile X Syndrome
  • Basal forebrain-ventral tegmental area glutamatergic pathway promotes emergence from isoflurane anesthesia in mice
Show more Neurobiology of Disease
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.